- Report
- November 2023
- 186 Pages
Asia Pacific
From €1368EUR$1,500USD£1,153GBP
- Report
- November 2023
- 181 Pages
Europe
From €1368EUR$1,500USD£1,153GBP
- Report
- October 2022
- 250 Pages
Global
From €3283EUR$3,600USD£2,766GBP
- Report
- October 2022
- 85 Pages
Europe
From €1368EUR$1,500USD£1,153GBP
- Report
- October 2022
- 87 Pages
Asia Pacific
From €1368EUR$1,500USD£1,153GBP
- Report
- October 2022
- 72 Pages
North America
From €1368EUR$1,500USD£1,153GBP
- Report
- August 2022
Global
€6384EUR$7,000USD£5,379GBP
- Report
- October 2023
- 360 Pages
Global
From €2356EUR$2,583USD£1,985GBP
€3365EUR$3,690USD£2,835GBP
- Book
- June 2018
- 368 Pages
- Book
- May 2012
- 528 Pages
- Book
- March 2018
- 440 Pages

The Cell Viability market is a subset of the biotechnology industry that focuses on the study of living cells and their ability to survive and thrive in different environments. It is a rapidly growing field of research, with applications in a variety of industries, including pharmaceuticals, medical diagnostics, and bioprocessing. Cell viability studies are used to assess the health of cells, determine the effects of various treatments, and identify potential new treatments.
Cell viability studies involve a variety of techniques, including cell culture, microscopy, flow cytometry, and molecular biology. These techniques are used to measure the number of viable cells, their metabolic activity, and their ability to respond to stimuli. Cell viability studies are also used to assess the effects of environmental factors, such as temperature, pH, and oxygen levels, on cell health.
Companies in the Cell Viability market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Promega Corporation, and Agilent Technologies. Show Less Read more